Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 14, 2025 • 12:00 AM ET

Date/Time Source News Release
12/19/2024 08:30 AM EST GlobeNewswire ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21
12/11/2024 06:30 AM EST GlobeNewswire ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners
11/14/2024 09:00 AM EST GlobeNewswire ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
10/22/2024 08:45 AM EDT GlobeNewswire ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners
08/15/2024 07:30 AM EDT GlobeNewswire ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements
04/17/2024 09:00 AM EDT GlobeNewswire ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
04/10/2024 08:30 AM EDT GlobeNewswire ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
03/26/2024 08:30 AM EDT GlobeNewswire ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
03/21/2024 08:30 AM EDT GlobeNewswire AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
02/27/2024 08:30 AM EST GlobeNewswire ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
Page

Additional News

As of August 14, 2025 • 12:00 AM ET

Date/Time Source News Release
08/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, August 13th, 2025
08/13/2025 05:31 AM EDT US Earnings Reports Expected earnings - ABVC BioPharma Inc.
08/12/2025 06:45 PM EDT KlickAnalytics ABVC - Historical Price Movements Surrounding Earnings
08/12/2025 06:40 PM EDT KlickAnalytics ABVC - Historical Earnings Price Analysis
08/08/2025 07:04 AM EDT NewMediaWire BioKey Stands as a Strategic U.S. Pharmaceutical Platform Amid Global Tariff Shifts
08/06/2025 07:37 AM EDT NewMediaWire ABVC BioPharma Gains Confidence From International Investors to Support Growth Path
08/01/2025 07:04 AM EDT NewMediaWire OncoX Deepens ABVC Alliance
07/24/2025 09:05 AM EDT NewMediaWire ABVC BioPharma Strengthens Oncology Partnership With $100,000 Milestone Payment From OncoX BioPharma
07/18/2025 09:07 AM EDT NewMediaWire ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program
07/10/2025 05:36 PM EDT NewMediaWire ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.